T. Hitotsumatsu et al., EXPRESSION OF NEUROFIBROMATOSIS-2 PROTEIN IN HUMAN BRAIN-TUMORS - AN IMMUNOHISTOCHEMICAL STUDY, Acta Neuropathologica, 93(3), 1997, pp. 225-232
The neurofibromatosis 2 (NF2) gene-encoded protein, named merlin, may
function as a molecular linkage connecting cytoskeleton and plasma mem
brane. Merlin is thought to play a crucial role as a tumor suppressor
not only in hereditary NF2-related tumors, but also in sporadic tumors
such as schwannomas, meningiomas and gliomas. Using a merlin-expressi
on vector system, we raised specific antiserum against merlin. We obse
rved the intracellular distribution of merlin in cultured glioma cells
, and further investigated merlin expression in 116 human brain tumors
. Immunofluorescence microscopy revealed that merlin was localized ben
eath the cell membrane and concentrated at cell-to-cell adhesion sites
, where actin filaments are densely associated with plasma membrane. B
y immunohistochemistry, none of the schwannomas from either NF2 patien
ts or sporadic cases showed any immunoreactivity, while normal Schwann
cells of cranial nerves were immunopositive. In meningiomas, merlin e
xpression was frequently seen in the meningothelial subtype (8/10, 80%
), but no expression could be detected in either the fibrous or the tr
ansitional variant. Most normal astrocytes were negative; however, rea
ctive astrocytes often expressed merlin. Glioblastomas and anaplastic
astrocytomas were found to be strongly positive, and focal positive st
aining was observed in fibrillary and pilocytic astrocytomas. Thus, th
e loss of merlin appears to be integral to schwannoma formation and th
e differential pathogenesis of meningioma subtypes. However, merlin al
terations do not appear to play a critical role in either the tumorige
nesis or malignant transformation of neoplastic astrocytes.